BioNexus Gene Lab Corp. completes Chemrex governance restructuring; appoints Matthew Barsing as Chairman

BioNexus Gene Lab Corp

Chemrex board streamlined to two directors: Matthew L. Barsing (Chairman) and Angeline Chong (Director, BioNexus CFO).
New officers expected in coming months; Chemrex remains wholly owned subsidiary under parent oversight.
July 2025 capital allocation framework approved for potential operational upgrades, subject to evaluation.
No definitive commitments on scope, timing, or scale of any initiative under evaluation.

item 8.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.